These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20822038)

  • 1. Fentanyl pectin nasal spray in breakthrough cancer pain.
    Taylor D; Galan V; Weinstein SM; Reyes E; Pupo-Araya AR; Rauck R;
    J Support Oncol; 2010; 8(4):184-90. PubMed ID: 20822038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of fentanyl pectin nasal spray compared with immediate-release morphine sulfate tablets in the treatment of breakthrough cancer pain: a multicenter, randomized, controlled, double-blind, double-dummy multiple-crossover study.
    Fallon M; Reale C; Davies A; Lux AE; Kumar K; Stachowiak A; Galvez R;
    J Support Oncol; 2011; 9(6):224-31. PubMed ID: 22055892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain.
    Portenoy RK; Burton AW; Gabrail N; Taylor D;
    Pain; 2010 Dec; 151(3):617-624. PubMed ID: 20800358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients.
    Portenoy RK; Raffaeli W; Torres LM; Sitte T; Deka AC; Herrera IG; Wallace MS;
    J Opioid Manag; 2010; 6(5):319-28. PubMed ID: 21046929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term tolerability, efficacy and acceptability of fentanyl pectin nasal spray for breakthrough cancer pain.
    Radbruch L; Torres LM; Ellershaw JE; Gatti A; Luis Lerzo G; Revnic J; Taylor D
    Support Care Cancer; 2012 Mar; 20(3):565-73. PubMed ID: 21424794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal fentanyl versus fentanyl pectin nasal spray for the management of breakthrough cancer pain in doses proportional to basal opioid regimen.
    Mercadante S; Prestia G; Adile C; Casuccio A
    J Pain; 2014 Jun; 15(6):602-7. PubMed ID: 24561001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain.
    Taylor D; Radbruch L; Revnic J; Torres LM; Ellershaw JE; Perelman M
    J Pain Symptom Manage; 2014 Jun; 47(6):1001-7. PubMed ID: 24128821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fentanyl Pectin Nasal Spray Versus Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Comparative Study.
    Mercadante S; Aielli F; Adile C; Costanzi A; Casuccio A
    J Pain Symptom Manage; 2016 Jul; 52(1):27-34. PubMed ID: 27208863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between onset of pain relief and patient satisfaction with fentanyl pectin nasal spray for breakthrough pain in cancer.
    Torres LM; Revnic J; Knight AD; Perelman M
    J Palliat Med; 2014 Oct; 17(10):1150-7. PubMed ID: 25211772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consistency of efficacy, patient acceptability, and nasal tolerability of fentanyl pectin nasal spray compared with immediate-release morphine sulfate in breakthrough cancer pain.
    Davies A; Sitte T; Elsner F; Reale C; Espinosa J; Brooks D; Fallon M
    J Pain Symptom Manage; 2011 Feb; 41(2):358-66. PubMed ID: 21334555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of fentanyl sublingual spray for the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study.
    Rauck R; Reynolds L; Geach J; Bull J; Stearns L; Scherlis M; Parikh N; Dillaha L
    Curr Med Res Opin; 2012 May; 28(5):859-70. PubMed ID: 22480131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fentanyl pectin nasal spray for breakthrough cancer pain.
    Taylor DR; Gabrail N
    Future Oncol; 2012 Feb; 8(2):121-30. PubMed ID: 22335576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain.
    Ueberall MA; Lorenzl S; Lux EA; Voltz R; Perelman M
    J Pain Res; 2016; 9():571-85. PubMed ID: 27574463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitation of accurate and effective radiation therapy using fentanyl pectin nasal spray (FPNS) to reduce incidental breakthrough pain due to procedure positioning.
    Prieto I; Pardo J; Luna J; Marin JP; Olivera J; Garcia AJ; Perez AM
    Scand J Pain; 2016 Apr; 11():52-58. PubMed ID: 28850470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial.
    Hui D; Kilgore K; Park M; Williams J; Liu D; Bruera E
    J Pain Symptom Manage; 2016 Oct; 52(4):459-468.e1. PubMed ID: 27401508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacokinetic assessment of an alternate titration strategy for fentanyl pectin nasal spray.
    Perelman M; Knight A
    Int J Clin Pharmacol Ther; 2013 Dec; 51(12):942-7. PubMed ID: 24120713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain.
    Dietrich E; Gums JG
    Ann Pharmacother; 2012 Oct; 46(10):1382-91. PubMed ID: 23012382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial.
    Mercadante S; Radbruch L; Davies A; Poulain P; Sitte T; Perkins P; Colberg T; Camba MA
    Curr Med Res Opin; 2009 Nov; 25(11):2805-15. PubMed ID: 19792837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.